Deals Counterparts

Bristol Myers Squibb

company
0
Deals
0
Technologies
0
Markets
0
Partners
Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. While not directly an infrastructure investor, their operations require significant energy consumption, making them a potential offtaker in renewable energy projects.